3SOF

G
I understand your TA and if I were running a public portfolio I would have done the same thing. However, when the shelf was announced, I stated that the company's plan was far sighted and I believe this is only the beginning of this new technology. One must ask why only 38mm? This in my opinion is dilution with a specific purpose. All fundamentalists view accretive dilution as a positive. We'll see how this plays out. People have viewed this as a bird flu play. In fact this is a manufacturing platform play.

Quote from: 1reilly on March 21, 2006, 10:13:30 AM
People have viewed this as a bird flu play. In fact this is a manufacturing platform play.

Can you elaborate on this idea?  I thought NVAX was licensing the stainless steel bath scalable manufacturing technology from another company?

I'm on the run today so I'll be brief. Vlp is a new technology related to the(manufacturing) creation of an antibody. When I say manufacturing I'm actually talking about a new process that is very mobile and swift in its ability to duplicate the antibody, not physical equipment.
I want to futher my question regarding the private placement. Why only 38mm? Dec 22 they filled a 100mm shelf. Yesterday the stock traded 15.5 mm shares or over 100mm in market value. They could easily have placed the whole shelf if their goal was to just bring in cash. I believe that the 38mm is targeted. It will be interesting to see where. The general purpose use of funds described in the PR leaves one wondering how did a number like 38mm come to mind. Think about it?

today will be interesting 

Novavax Executes Definitive Agreement for $38 Million Public Offering
Tuesday March 21, 7:50 am ET

MALVERN, Pa., March 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX - News) today announced that it has entered into a definitive agreement for a $38 million registered direct offering of 5,205,479 shares of its common stock at a price of $7.30 per share. The shares of common stock will be issued pursuant to an effective shelf registration statement.

Rodman & Renshaw, LLC acted as the exclusive placement agent for the offering.

SURPRISE SURPRISE

Rodman & Renshaw set a target of 10 for NVAX a few days ago. Nor we learn they as exclusive placement agents.

jorgegr

The dilution news killed what probably would have been a "big air" day for NVAX otherwise. Look at GNBT today. That could've been NVAX. If NVAX hadn't diluted today I think we would have seen a similar spike. Bummer.

Keep NVAX on your radars. Pulled back to the shelf price (predictable), might set up re-entry around the 9ema / shelf price area. Will need to base some here for a few days to get the setup in place.

update:
NVAX: Short Interest UP 1.3% to 4.1M in Mar 2006
Friday , March 24, 2006 16:20 ET

According to new short interest data from NASDAQ, short interest for Novavax, Inc. (NasdaqNM: NVAX) INCREASED 1.3% to 4,121,351 shares for the month ended mid-March, 2006.

SYMBOL       FEBRUARY           MARCH          CHANGE       %CHANGE      DAYS/COVER
--------   -------------   -------------   -------------  ------------  ----------
NVAX           4,069,880       4,121,351         +51,471        +1.26%           1

Based on NVAX's 20-day average daily share volume of 8,787,890, it would require approximately 1 day(s) of buying to cover this short interest.

heading higher again?

cheers
O.

very bullish news; time for reentering ?
Premarket:8.33 $ 

Novavax Bond Holders Elect to Convert $7.0 Million of Outstanding Notes
Friday March 31, 7:00 am ET

MALVERN, Pa., March 31 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX - News), announced today that certain holders of $7.0 million face amount of the company's 4.75% senior convertible notes due July 15, 2009 (the "Notes") exercised their optional conversion right to convert such Notes into 1,294,564 shares of Novavax Common Stock at the per share conversion price of $5.46.

As a result of the conversion, the aggregate principal amount of Notes outstanding will be reduced from $29.0 million to $22.0 million and the company's stockholders' equity will be increased by the same amount. In addition the company's annual interest expense will be reduced by $332,500. With this conversion, the total outstanding shares of Novavax increases to 61.3 million.

With the good news and overwhelmingly strong bird flu hype NVAX seems to be defying gravity for the meanwhile. Chart is exponentially increasing making an entrance more risky. 

And I have a question for bird flu speculators: Why NVAX over other bird flu stocks like GNBT or AVII?

Anyone one of you consider re-enter at this level?

Quote from: [D] Investor on March 31, 2006, 09:04:59 AM
With the good news and overwhelmingly strong bird flu hype NVAX seems to be defying gravity for the meanwhile. Chart is exponentially increasing making an entrance more risky. 

And I have a question for bird flu speculators: Why NVAX over other bird flu stocks like GNBT or AVII?

well, I am thinking about SVA also !
(check the board anaylsis)

cheers
O.

Quote from: [D] Investor on March 31, 2006, 09:04:59 AM
Chart is exponentially increasing making an entrance more risky. 

DInvestor,

Good read.  Applause.  NVAX got whacked this afternoon.

NVAX completed a Double Top on the break of 7.00.  I didn't see any news, but even with news, this looks like technical selling on the pattern break.  We can see on the intraday chart (last post) how the stock cratered when 7.00 got taken out. 

The break of the Double Top puts a target of 5.69 IN PLAY, near the 50DMA.

Quote from: Melf Elf on April 04, 2006, 04:07:02 PM
The break of the Double Top puts a target of 5.69 IN PLAY, near the 50DMA.

For a minute there yesterday, I thought NVAX was going to hit 5.69 on the early morning tank.  The 50DMA is right there, too, at 5.69,  but buyers stepped in at 5.85.  FWIW, I would peg near-term resistance at 7.00 - 7.12 if NVAX continues to rally.

1. 7.00, the March 29 low, is where the Double Top broke.

2. 7.09 is the March 23 low.

3. 7.12 is the Tenkan-Sen, basis the Ichimoku Kinko Hyo chart.  That's somewhat like an 8-Day price-related MACD.  It probably will come down a little each day.

anyone got a good entry point for NVAX after the recent fall, are we considering <$6 or around 5.8 or have i missed it